GelMEDIX, Catalent Partner to Advance Stem Cell Vision Therapies
GelMEDIX Inc. and Catalent, Inc. have announced a global partnership aimed at advancing regenerative therapies designed to restore vision in patients with ocular and retinal diseases.…
Read More...
Read More...
